reports
electroCore to Participate in Upcoming Investor Conferences
electroCore to Participate in Upcoming Investor Conferences ROCKAWAY, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor events: October 1 - Management will participate in one-on-one meetings at the October 17 -- Management will participate in a fireside chat with Anthony Vendetti, the Director of Research and Senior Healthcare Analyst, at the October 29 - Management will participate in one-on-one meetings, and host a grou...
electroCore Engages FNK IR to Execute Expanded Investor Relations Prog...
electroCore Engages FNK IR to Execute Expanded Investor Relations Program ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an institutionally focused investor relations consulting firm, to develop and deploy an expanded outreach and communications program. Dan Goldberger, Chief Executive Officer of electroCore, commented, “electroCore has demonstrated strong financial performance, delivering seven consecutive quarters of record revenue and dr...
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effectiv...
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training Clinical trial demonstrates the ability of nVNS to accelerate sensorimotor learning in USAF Simulator Based Pilot Training ROCKAWAY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) presented new results supporting the ability of electroCore’s TAC-STIM (nVNS) to accelerate pilot training. The presentation title...
electroCore to Participate in the H.C. Wainwright 26th Annual Global I...
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference ROCKAWAY, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the 26th Annual H.C. Wainwright Global Investment Conference taking place in New York City on September 9-11, 2024. Dan Goldberger, the company’s Chief Executive Officer, will participate in a fireside chat on Wednesday, September 11th, at 12:00 PM ET. Mr. Goldberger will also be available for 1x1 meetin...
electroCore to Participate in Upcoming Investor Conferences
electroCore to Participate in Upcoming Investor Conferences ROCKAWAY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s CEO, Dan Goldberger, is scheduled to participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference August 12 - 13, 2024. Please contact Needham to schedule a 1x1 meeting. In addition, Brian Posner, CFO of electroCore, Inc. is scheduled to attend the 44th Annual Canaccord Genuity Growth Conference taking place at InterContinental...
electroCore Announces Second Quarter 2024 Financial Results
electroCore Announces Second Quarter 2024 Financial Results Seventh consecutive record quarterly net sales of $6.1 million, an increase of 73% over second quarter 2023 Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ROCKAWAY, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company and wellness company, today announced second quarter 2024 financial results. Recent Highlights •Net loss of $2.7 million, a decrease of 46% over second quarter 2023 •Launched our direct-to-consumer mobile ...
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(...
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) ROCKAWAY, N.J., Aug. 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on August 1, 2024, Stephen Smith joined electroCore as the Company’s VP, Quality, Regulatory, and Compliance, and the Compensation Committee of electroCore’s Board of Directors granted 10,000 restricted stock units (“RSUs”) to Mr. Smith in connection with the commencement of his employment. The RSUs were granted as an inducement ma...
Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerati...
Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning Clinical Trial demonstrates that nVNS is an effective learning acceleration tool while simultaneously improving focus and decreasing fatigue in study participants ROCKAWAY, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) published a paper entitled “Transcutaneous Cervical Vagus Nerve Stimulation Enhances Second-Language Vocabulary Acquisi...
electroCore to Announce Second Quarter June 30, 2024 Financial Results...
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 ROCKAWAY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the second quarter ended June 30, 2024, after the close of the market on Wednesday, August 7, 2024. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions. Wednesday, August 7, 4:30 PM EDTDial-In: 877-407-8835 / Conferen...
electroCore Announces the Commercial Launch of TAC-STIM™
electroCore Announces the Commercial Launch of TAC-STIM™ Upgraded TAC-STIM enhances Energy, Focus and Readiness ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the Shelf (COTS) availability of the next generation TAC-STIM™, a non-invasive vagus nerve stimulator (nVNS) designed in partnership with the US military to enhance human performance exclusively for active-duty military use. TAC-STIM is a cutting-edge device that can accelerate learning...
electroCore to Join Russell Microcap® Index
electroCore to Join Russell Microcap® Index ROCKAWAY, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its stock is on the preliminary additions list for inclusion in the Russell Microcap® Index after its 2024 annual reconstitution. The newly reconstituted indexes will take effect after the market close on June 28, 2024, with the newly effective reconstituted family of indices beginning trading after the open of trading on July 1, 2024, according to a preliminary list of additions...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TGI TRIUMPH GROUP INC.
PBF PBF ENERGY INC. CLASS A
GLP GLOBAL PARTNERS LP
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
LEG LEGGETT & PLATT INCORPORATED
NSC NORFOLK SOUTHERN CORPORATION
SPWR SUNPOWER CORPORATION
CSWC CAPITAL SOUTHWEST CORP.
EVBN EVANS BANCORP INC.
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
BOMN BOSTON OMAHA
BCBP BCB BANCORP INC.
FRAF FRANKLIN FINANCIAL SERVICES CO.
ECOR ELECTROCORE
LSBK LAKE SHORE BANCORP INC.
TCPC BLACKROCK TCP CAPITAL CORP.
CBNK CAPITAL BANCORP
RRBI RED RIVER BANCSHARES
PCB PACIFIC CITY FINANCIAL CORP
HQL TEKLA LIFE SCIENCES INVESTORS
ABCL ABCELLERA BIOLOGICS
FTHM FATHOM HOLDINGS
AFCG AFC GAMMA
RSVR RESERVOIR MEDIA
TMCI INC.
NSPR TREACE MED CONCEPTS INC
TRDA INSPIREMD INC
MEGI ENTRADA THERAPEUTICS INC
GRNT MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
WGS GRANITE RIDGE RESOURCES INC
LTH GENEDX HOLDINGS CORP.
OPAD LIFE TIME GROUP HLDGS INC
AEI OFFERPAD SOLUTIONS INC
BHRB ALSET INC.
BEEP BURKE HERBERT FINANCIAL SERVICES CORP
MOBILE INFRASTRUCTURE CORPORATION NEW
- Jonathan Moreland
FFIN FIRST FINANCIAL BANKSHARES INC
LEG LEGGETT & PLATT INCORPORATED
UBFO UNITED SECURITY BANCSHARE
BOMN BOSTON OMAHA
BCBP BCB BANCORP INC.
BTAI BIOXCEL THERAPEUTICS
ECOR ELECTROCORE
ZM ZOOM VIDEO COMMUNICATIONS
RRBI INC.
FTHM RED RIVER BANCSHARES
AFCG FATHOM HOLDINGS
RSVR AFC GAMMA
XPON RESERVOIR MEDIA
OPAD INC.
AEI EXPION360 INC
BEEP OFFERPAD SOLUTIONS INC
ALSET INC.
MOBILE INFRASTRUCTURE CORPORATION NEW
electroCore, Inc. Announces Closing of $9.3 Million Registered Direct ...
electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules ROCKAWAY, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced the closing of its previously announced registered direct offering of 225,000 registered pre-funded warrants to purchase shares of common stock (the “registered pre-funded warrants”) to an institutional accredited investor; the concurrent private pl...
electroCore, Inc. Announces $9.3 Million Registered Direct Offering an...
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced that it has agreed to issue and sell to an institutional accredited investor an aggregate of 225,000 registered pre-funded warrants to purchase shares of common stock and unregistered warrants to purchase up to an aggregate of 112,500 shares of common stock. T...
electroCore Announces First Quarter 2024 Financial Results
electroCore Announces First Quarter 2024 Financial Results Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023Company to host a conference call and webcast today, May 8, 2024 at 4:30 PM EST ROCKAWAY, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company and wellness company, today announced first quarter 2024 financial results. Recent Highlights Record revenue of $5.4 million, an increase of 96% over first quarter 2023Launched our direct-to-consumer mobile app-enabled produc...
- Jonathan Moreland
RF REGIONS FINANCIAL CORPORATION
NEOG NEOGEN CORPORATION
LGND LIGAND PHARMACEUTICALS INCORPORATED
INTC INTEL CORPORATION
HXL HEXCEL CORPORATION
FFIN FIRST FINANCIAL BANKSHARES INC
EGBN EAGLE BANCORP INC.
DLTR DOLLAR TREE INC.
CINF CINCINNATI FINANCIAL CORPORATION
CHDN CHURCHILL DOWNS INCORPORATED
SWKS SKYWORKS SOLUTIONS INC.
HTLD HEARTLAND EXPRESS INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
CET CENTRAL SECURITIES CORP.
LIND LINDBLAD EXPEDITIONS HOLDINGS
WDFC WD-40 COMPANY
FEIM FREQUENCY ELECTRONICS INC.
AINC ASHFORD
CLF CLIFFS NATURAL RESOURCES INC.
PWOD PENNS WOODS BANCORP INC.
ATOM ATOMERA
LOVE LOVESAC
FVCB FVCBANKCORP
INMB INMUNE BIO
MCFT INC.
CAPR MASTERCRAFT BOAT HOLDINGS
RYES CAPRICOR THERAPEUTICS
HQL PATRIOT MINEFINDERS INC.
SOWG TEKLA LIFE SCIENCES INVESTORS
CPZ SOW GOOD INC.
AUID CALAMOS LONG/SHORT EQUITY AND DYNAMIC INCOME TRUST
JBHT IPSIDY INC.
TBBK J.B. HUNT TRANSPORT SERVICES
MPA INC.
FTHY THE BANCORP
AIKI INC.
BHVN BLACKROCK MUNIYIELD PENNSYLVANIA FD
BUKS FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
ACRV AIKIDO PHARMA INC.
ZURA BIOHAVEN LTD
ABEO BUTLER NATIONAL CORP
STCN ACRIVON THERAPEUTICS INC
KRRO ZURA BIO LTD
LSXMA ABEONA THERAPEUTICS INC.
EP STEEL CONNECT INC
INTZ KORRO BIO INC
LGVN LIBERTY SIRIUSXM GROUP
OCX EMPIRE PETROLEUM CORP
EYPT INTRUSION INC
IZEA LONGEVERON INC
CFFI ONCOCYTE CORPORATION
EYEPOINT PHARMACEUTICALS
INC.
IZEA WORLDWIDE INC
C&F FINANCIAL CORPORATION
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(...
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2024, Donald Melnikoff joined electroCore as the Company’s SVP, Engineering, Regulatory, and Compliance; the Compensation Committee of electroCore’s Board of Directors granted 10,000 restricted stock units (“RSUs”) to Mr. Melnikoff in connection with the commencement of his employment. The RSUs were granted as an inducemen...
electroCore to Announce First Quarter March 31, 2024 Financial Results...
electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024 ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of the market on Wednesday, May 8, 2024. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions. Wednesday, May 8, 4:30 PM EDTDomestic: 877-407-8835International: Conferen...
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, P...
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of its most recent Truvaga Plus consumer study conducted earlier this year. Based on a 30-day in-home use test by an independent third-party research firm, Truvaga Plus helped its users improve sleep, focus, stress, energy, and mood. 39 participants were instructed to use the Truvaga Plus pro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.